Article
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.
Cardiovascular drugs and therapy - 1 Jun 2021
Torramade-Moix Sergi, Palomo Marta, Vera Manel, Jerez Didac, Moreno-Castaño Ana Belen, Zafar M Urooj, Rovira Jordi, Diekmann Fritz, Garcia-Pagan Joan Carles, Escolar Gines, Cases Aleix, Diaz-Ricart Maribel
Abstract excerpt
PURPOSE: Chronic kidney disease (CKD) associates with inflammatory and prothrombotic phenotypes, resulting in higher cardiovascular risk. Factor Xa displays functions beyond coagulation, exhibiting proinflammatory effects. The aim of the present study was to investigate whether a direct FXa inhibitor protects from the endothelial dysfunction (ED) caused by uremia. METHODS: Macro (HUVEC) and microvascular (HMEC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
